Kaddar Rochdi, Tarik Chayma, Atmani Maryam, Enakhil Ikrame, Fakhri Nada, Khalis Mohamed, Lotfy Abdellah, El Kadmiri Nadia
International School of Public Health, Mohammed VI University of Health Sciences, Casablanca, Morocco.
Regional Direction of Health and Social Protection, Souss Massa Region, Agadir City, Morocco.
Bull Natl Res Cent. 2022;46(1):142. doi: 10.1186/s42269-022-00827-8. Epub 2022 May 16.
The implementation of coronavirus disease of 2019 (COVID-19) lockdown has affected the daily practices of subjects with chronic diseases such as diabetes and caused negative impact on their lifestyle and habits such as physical activity, dietary habits and accessibility to medications. Diabetic people are considered the most vulnerable groups to COVID-19, and the lockdown measure has disturbed the diabetes self-management. In our study, we aimed to assess, for the first time at the regional level (Souss Massa Region), the COVID-19 lockdown impact on HbA1c levels in patients with type 1 diabetes (T1D) and type 2 diabetes (T2D). We carried out a cross-sectional quantitative analysis at the health center of the industrial district in Agadir City.
We found a significant improvement in post-lockdown mean ± SD HbA1c in 150 subjects suffering from T1D and T2D; = 0.005). Our analysis revealed a significant association of HbA1c deviation with educational level and medical coverage ( = 0.01). No significant association was detected between HbA1c deviation and age, gender, weight, height, current BMI status, fasting blood sugar, family history, urban or rural areas, marital status, professional activity, socioeconomic income, type of diabetes, dietary, comorbidities, diabetic complications, housing, adherence to the dietary recommendations, physical activity, medical appointments, stopping medication, self-monitoring, fasting and anxiety about getting COVID-19.
COVID-19 lockdown had no deleterious effect on HbA1c levels in Moroccan patients with T1D and T2D.
2019年冠状病毒病(COVID-19)封锁措施的实施影响了糖尿病等慢性病患者的日常行为,对他们的生活方式和习惯,如体育活动、饮食习惯及药物可及性产生了负面影响。糖尿病患者被认为是最易感染COVID-19的群体,封锁措施扰乱了糖尿病的自我管理。在我们的研究中,我们旨在首次在地区层面(苏斯-马萨地区)评估COVID-19封锁对1型糖尿病(T1D)和2型糖尿病(T2D)患者糖化血红蛋白(HbA1c)水平的影响。我们在阿加迪尔市工业区的健康中心进行了一项横断面定量分析。
我们发现,在150名T1D和T2D患者中,封锁后平均±标准差的HbA1c有显著改善(P = 0.005)。我们的分析显示,HbA1c偏差与教育水平和医疗覆盖情况存在显著关联(P = 0.01)。未检测到HbA1c偏差与年龄、性别、体重、身高、当前体重指数(BMI)状态、空腹血糖、家族病史、城乡地区、婚姻状况、职业活动、社会经济收入、糖尿病类型、饮食、合并症、糖尿病并发症、住房、对饮食建议的依从性、体育活动、医疗预约、停药、自我监测、禁食以及对感染COVID-19的焦虑之间存在显著关联。
COVID-19封锁对摩洛哥T1D和T2D患者的HbA1c水平没有有害影响。